SCHEMBL2925473

SCHEMBL2925473

N#C[C@@H](C(N)=O)c1ccc(-c2cccnc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 10/20 0.55
MKNK2 Q9HBH9 10/20 0.55
CYP11B2 P19099 2/20 0.50
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
PARP1 P09874 1/20 0.43
DHODH Q02127 1/20 0.43
PARP2 Q9UGN5 1/20 0.43
CYP2A6 P11509 2/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
LRRK2 Q5S007 1/20 0.42
IKBKB O14920 1/20 0.41
CYP17A1 P05093 1/20 0.40
CYP11B1 P15538 1/20 0.40
CHEK2 O96017 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3661241 0.83 PTGS2 (0.46) DHODHALDH1A1CYP1A2CYP3A4IKBKB
SCHEMBL4369739 0.79 MKNK1 (0.61) MKNK1MKNK2CA12CA1CA2
SCHEMBL30338756 0.78 MKNK1 (0.59) MKNK1MKNK2CA12CA1CA2
SCHEMBL6026 0.74 MKNK1 (0.55) MKNK1MKNK2CA12CA1CA2
SCHEMBL3057993 0.74 MKNK1 (0.50) MKNK1MKNK2ALDH1A1CYP17A1
SCHEMBL2927032 0.72 TSHR (0.48) ALDH1A1CYP1A2
SCHEMBL2771881 0.72 TSHR (0.48) ALDH1A1CYP1A2
SCHEMBL606654 0.72 MKNK1 (1.00) MKNK1MKNK2CA12CA1CA2
SCHEMBL30855339 0.72 MKNK1 (1.00) MKNK1MKNK2CA12CA1CA2
SCHEMBL25279495 0.71 PSEN1 (0.59) MKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2225196-A1 CYSTEINE PROTEASE INHIBITORS FOR THE TREATMENT OF PARASITIC DISEASES Merck Frosst Canada Ltd. (CA) 2010-09-08 EP disclosed
WO-2009067797-A1 CYSTEINE PROTEASE INHIBITORS FOR THE TREATMENT OF PARASITIC DISEASES MERCK FROSST CANADA LTD. (CA) 2009-06-04 WO disclosed